Precision Medicine in Hymenoptera Venom Allergy: Diagnostics, Biomarkers, and Therapy of Different Endotypes and Phenotypes
Open Access
- 22 October 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11, 579409
Abstract
Allergic reactions to stings of Hymenoptera species may be severe and are potentially fatal deviations of the immunological response observed in healthy individuals. However, venom-specific immunotherapy (VIT) is an immunomodulatory approach able to cure venom allergy in the majority of affected patients. An appropriate therapeutic intervention and the efficacy of VIT not only depend on a conclusive diagnosis, but might also be influenced by the patient-specific manifestation of the disease. As with other diseases, it should be borne in mind that there are different endotypes and phenotypes of venom allergy, each of which require a patient-tailored disease management and treatment scheme. Reviewed here are different endotypes of sting reactions such as IgE-mediated allergy, asymptomatic sensitization or a simultaneous presence of venom allergy and mast cell disorders including particular considerations for diagnosis and therapy. Additionally, phenotypical manifestations of venom allergy, as e.g. differences in age of onset and disease severity, multiple sensitization or patients unsusceptible to therapy, are described. Moreover, biomarkers and diagnostic strategies that might reflect the immunological status of the patient and their value for therapeutic guidance are discussed. Taken together, the increasing knowledge of different disease manifestations in venom hypersensitivity and the growing availability of diagnostic tools open new options for the classification of venom allergy and, hence, for personalized medical approaches and precision medicine in Hymenoptera venom allergy.Keywords
Funding Information
- Helmholtz Association
This publication has 210 references indexed in Scilit:
- Birch pollen immunotherapy results in long-term loss of Bet v 1–specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodiesJournal of Allergy and Clinical Immunology, 2012
- High sensitivity of CAP-FEIA rVes v 5 and rVes v 1 for diagnosis of Vespula venom allergyJournal of Allergy and Clinical Immunology, 2012
- Component‐resolved diagnosis of vespid venom‐allergic individuals: phospholipases and antigen 5s are necessary to identify Vespula or Polistes sensitizationAllergy, 2012
- Immunology in the Clinic Review Series; focus on allergies: basophils as biomarkers for assessing immune modulationClinical and Experimental Immunology, 2011
- Multiple epinephrine doses for stinging insect hypersensitivity reactions treated in the emergency departmentAnnals of Allergy, Asthma & Immunology, 2010
- Mechanisms of IgE-mediated allergyExperimental Cell Research, 2010
- Basophil sensitivity through CD63 or CD203c is a functional measure for specific immunotherapyClinical and Molecular Allergy, 2010
- Insect Sting AnaphylaxisImmunology and Allergy Clinics of North America, 2007
- An epidemiologic study of insect allergy in children. I. Characteristics of the diseaseThe Journal of Pediatrics, 1982
- A Controlled Trial of Immunotherapy in Insect HypersensitivityNew England Journal of Medicine, 1978